Linezolid Therapy of Staphylococcus aureus Experimental Osteomyelitis

The in vivo activity of linezolid or cefazolin against a clinical isolate of methicillin-susceptible Staphylococcus aureus (linezolid MIC, 2 μg/ml) was studied in a rat model of experimental osteomyelitis. Sixty rats with experimental S. aureus osteomyelitis were treated for 21 days with no antimicr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Patel, Robin, Piper, Kerryl E., Rouse, Mark S., Steckelberg, James M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11083654/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.12.3438-3440.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!